|
1
|
McLachlan SM and Rapoport B: Thyroid
autoantibodies display both ‘Original antigenic sin’ and epitope
spreading. Front Immunol. 8:18452017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Furmaniak J, Sanders J, Núñez Miguel R and
Rees Smith B: Mechanisms of action of TSHR autoantibodies. Horm
Metab Res. 47:735–752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Furmaniak J, Sanders J, Sanders P, Li Y
and Rees Smith B: TSH receptor specific monoclonal autoantibody
K1-70TM targeting of the TSH receptor in subjects with
Graves' disease and Graves' orbitopathy-Results from a phase I
clinical trial. Clin Endocrinol (Oxf). 96:878–887. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gupta AK and Kumar S: Utility of
antibodies in the diagnoses of thyroid diseases: A review article.
Cureus. 14:e312332022.PubMed/NCBI
|
|
5
|
Smith TJ and Hegedüs L: Graves' disease. N
Engl J Med. 375:1552–1565. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Latif R, Mezei M, Morshed SA, Ma R,
Ehrlich R and Davies TF: A Modifying autoantigen in Graves'
disease. Endocrinology. 160:1008–1020. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Núñez Miguel R, Sanders P, Allen L, Evans
M, Holly M, Johnson W, Sullivan A, Sanders J, Furmaniak J and Rees
Smith B: Structure of full-length TSH receptor in complex with
antibody K1-70™. J Mol Endocrinol. 70:e2201202022.PubMed/NCBI
|
|
8
|
George A, Diana T, Längericht J and Kahaly
GJ: Stimulatory thyrotropin receptor antibodies are a biomarker for
graves' orbitopathy. Front Endocrinol (Lausanne). 11:6299252021.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lytton SD, Schluter A and Banga PJ:
Functional diagnostics for thyrotropin hormone receptor
autoantibodies: Bioassays prevail over binding assays. Front Biosci
(Landmark Ed). 23:2028–2043. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bahn RS: Current Insights into the
Pathogenesis of Graves' Ophthalmopathy. Horm Metab Res. 47:773–778.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Faßbender J, Holthoff HP, Li Z and Ungerer
M: Therapeutic effects of short cyclic and combined epitope
peptides in a Long-term model of Graves' disease and orbitopathy.
Thyroid. 29:258–267. 2019. View Article : Google Scholar
|
|
12
|
Rapoport B, Aliesky HA, Chen CR and
McLachlan SM: Evidence that TSH receptor A-subunit multimers, not
monomers, drive antibody affinity maturation in Graves' disease. J
Clin Endocrinol Metab. 100:E871–E875. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li CW, Osman R, Menconi F, Concepcion E
and Tomer Y: Cepharanthine blocks TSH receptor peptide presentation
by HLA-DR3: Therapeutic implications to Graves' disease. J
Autoimmun. 108:1024022020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Holthoff HP, Goebel S, Li Z, Faßbender J,
Reimann A, Zeibig S, Lohse MJ, Münch G and Ungerer M: Prolonged TSH
receptor A subunit immunization of female mice leads to a long-term
model of Graves' disease, tachycardia, and cardiac hypertrophy.
Endocrinology. 156:1577–1589. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rapoport B, Chazenbalk GD, Jaume JC and
McLachlan SM: The thyrotropin (TSH) receptor: Interaction with TSH
and autoantibodies. Endocr Rev. 19:673–716. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davies TF, Ando T, Lin RY, Tomer Y and
Latif R: Thyrotropin receptor-associated diseases: From adenomata
to Graves disease. J Clin Invest. 115:1972–1983. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Latif R, Teixeira A, Michalek K, Ali MR,
Schlesinger M, Baliram R, Morshed SA and Davies TF: Antibody
protection reveals extended epitopes on the human TSH receptor.
PLoS One. 7:e446692012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marcinkowski P, Kreuchwig A, Mendieta S,
Hoyer I, Witte F, Furkert J, Rutz C, Lentz D, Krause G and Schülein
R: Thyrotropin receptor: Allosteric modulators illuminate
intramolecular signaling mechanisms at the interface of Ecto- and
transmembrane domain. Mol Pharmacol. 96:452–462. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thyroid disease, . Assessment and
management. London: National Institute for Health and Care
Excellence (NICE); November 20–2019
|
|
20
|
Holthoff HP, Uhland K, Kovacs GL, Reimann
A, Adler K, Wenhart C and Ungerer M: Thyroid-stimulating hormone
receptor (TSHR) fusion proteins in Graves' disease. J Endocrinol.
246:135–147. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Y, Xia Q, Zhou L, Zhang Y, Guan Z,
Zhang J, Li Z, Liu K, Li B, Shao D, et al: B602L-Fc fusion protein
enhances the immunogenicity of the B602L protein of the African
swine fever virus. Front Immunol. 14:11862992023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Percie du Sert N, Hurst V, Ahluwalia A,
Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl
U, et al: The ARRIVE guidelines 2.0: Updated guidelines for
reporting animal research. PLoS Biol. 18:e30004102020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng H, Xu J, Chu Y, Jiang W, Yao W, Mo
S, Song X and Zhou J: A global regulatory network for dysregulated
gene expression and abnormal metabolic signaling in immune cells in
the microenvironment of Graves' disease and Hashimoto's
thyroiditis. Front Immunol. 13:8798242022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kristensen B: Regulatory B and T cell
responses in patients with autoimmune thyroid disease and healthy
controls. Dan Med J. 63:B51772016.PubMed/NCBI
|
|
25
|
Hsu WT, Suen JL and Chiang BL: The role of
CD4CD25 T cells in autoantibody production in murine lupus. Clin
Exp Immunol. 145:513–519. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arndt B, Witkowski L, Ellwart J and
Seissler J: CD8+ CD122+ PD-1-effector cells promote the development
of diabetes in NOD mice. J Leukoc Biol. 97:111–120. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benvenga S, Elia G, Ragusa F, Paparo SR,
Sturniolo MM, Ferrari SM, Antonelli A and Fallahi P: Endocrine
disruptors and thyroid autoimmunity. Best Pract Res Clin Endocrinol
Metab. 34:1013772020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Taylor PN, Albrecht D, Scholz A,
Gutierrez-Buey G, Lazarus JH, Dayan CM and Okosieme OE: Global
epidemiology of hyperthyroidism and hypothyroidism. Nat Rev
Endocrinol. 14:301–316. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Duan J, Xu P, Cheng X, Mao C, Croll T, He
X, Shi J, Luan X, Yin W, You E, et al: Structures of full-length
glycoprotein hormone receptor signalling complexes. Nature.
598:688–692. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang X, Liu H, Chen X, Chen PH, Fischer
D, Sriraman V, Yu HN, Arkinstall S and He X: Structure of
follicle-stimulating hormone in complex with the entire ectodomain
of its receptor. Proc Natl Acad Sci USA. 109:12491–12496. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kleinau G, Mueller S, Jaeschke H, Grzesik
P, Neumann S, Diehl A, Paschke R and Krause G: Defining structural
and functional dimensions of the extracellular thyrotropin receptor
region. J Biol Chem. 286:22622–22631. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rapoport B and McLachlan SM: TSH receptor
cleavage into subunits and shedding of the A-subunit; a molecular
and clinical perspective. Endocr Rev. 37:114–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Couët J, de Bernard S, Loosfelt H, Saunier
B, Milgrom E and Misrahi M: Cell surface protein
disulfide-isomerase is involved in the shedding of human
thyrotropin receptor ectodomain. Biochemistry. 35:14800–14805.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Duan J, Xu P, Luan X, Ji Y, He X, Song N,
Yuan Q, Jin Y, Cheng X, Jiang H, et al: Hormone- and
antibody-mediated activation of the thyrotropin receptor. Nature.
609:854–859. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Faust B, Billesbølle CB, Suomivuori CM,
Singh I, Zhang K, Hoppe N, Pinto AFM, Diedrich JK, Muftuoglu Y,
Szkudlinski MW, et al: Autoantibody mimicry of hormone action at
the thyrotropin receptor. Nature. 609:846–853. 2022.PubMed/NCBI
|
|
36
|
Morshed SA and Davies TF: Graves' disease
mechanisms: The role of stimulating, blocking, and cleavage region
TSH receptor antibodies. Horm Metab Res. 47:727–734. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Akamizu T, Kosugi S, Kohn LD and Mori T:
Anti-thyrotropin (TSH) receptor antibody binding epitopes of TSH
receptor: Site-directed mutagenesis approach. Nihon Rinsho.
52:1024–1030. 1994.(In Japanese). PubMed/NCBI
|
|
38
|
Zulkarnain Z, Ulhaq ZS, Sujuti H,
Soeatmadji DW, Zufry H, Wuragil DK, Marhendra APW, Riawan W,
Kurniawati S, Oktanella Y and Aulanni'am A: Comparative performance
of ELISA and dot blot assay for TSH-receptor antibody detection in
Graves' disease. J Clin Lab Anal. 36:e242882022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
McLachlan SM, Aliesky HA, Garcia P,
Banuelos B and Rapoport B: Thyroid hemiagenesis in a thyroiditis
prone mouse strain. Eur Thyroid J. 7:187–192. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rapoport B, Aliesky HA, Banuelos B, Chen
CR and McLachlan SM: A unique mouse strain that develops
spontaneous, Iodine-accelerated, pathogenic antibodies to the human
thyrotrophin receptor. J Immunol. 194:4154–4161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schlüter A, Horstmann M, Diaz-Cano S,
Plöhn S, Stähr K, Mattheis S, Oeverhaus M, Lang S, Flögel U,
Berchner-Pfannschmidt U, et al: Genetic immunization with mouse
thyrotrophin hormone receptor plasmid breaks Self-tolerance for a
murine model of autoimmune thyroid disease and Graves' orbitopathy.
Clin Exp Immunol. 191:255–267. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Porowińska D, Wujak M, Roszek K and
Komoszyński M: Prokaryotic expression systems. Postepy Hig Med Dosw
(Online). 67:119–129. 2013.(In Polish). View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Costagliola S, Alcalde L, Tonacchera M,
Ruf J, Vassart G and Ludgate M: Induction of thyrotropin receptor
(TSH-R) autoantibodies and thyroiditis in mice immunised with the
recombinant TSH-R. Biochem Biophys Res Commun. 199:1027–1034. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Janyga S, Marek B, Kajdaniuk D,
Ogrodowczyk-Bobik M, Urbanek A and Bułdak Ł: CD4+ cells in
autoimmune thyroid disease. Endokrynol Pol. 72:572–583. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yin L, Zeng C, Yao J and Shen J: Emerging
roles for noncoding RNAs in autoimmune thyroid disease.
Endocrinology. 161:bqaa0532020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sakaguchi S, Mikami N, Wing JB, Tanaka A,
Ichiyama K and Ohkura N: Regulatory T cells and human disease. Annu
Rev Immunol. 38:541–566. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Grindebacke H, Wing K, Andersson AC,
Suri-Payer E, Rak S and Rudin A: Defective suppression of Th2
cytokines by CD4CD25 regulatory T cells in birch allergics during
birch pollen season. Clin Exp Allergy. 34:1364–1372. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rosenberger S, Undeutsch R, Akbarzadeh R,
Ohmes J, Enghard P, Riemekasten G and Humrich JY: Regulatory T
cells inhibit autoantigen-specific CD4+ T cell responses in
lupus-prone NZB/W F1 mice. Front Immunol. 14:12541762023.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yan JJ, Lee JG, Jang JY, Koo TY, Ahn C and
Yang J: IL-2/anti-IL-2 complexes ameliorate lupus nephritis by
expansion of CD4+CD25+Foxp3+ regulatory T cells. Kidney Int.
91:603–615. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Malek TR and Castro I: Interleukin-2
receptor signaling: At the interface between tolerance and
immunity. Immunity. 33:153–165. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rifa'i M, Kawamoto Y, Nakashima I and
Suzuki H: Essential roles of CD8+CD122+ regulatory T cells in the
maintenance of T cell homeostasis. J Exp Med. 200:1123–1134. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yuan X, Dong Y, Tsurushita N, Tso JY and
Fu W: CD122 blockade restores immunological tolerance in autoimmune
type 1 diabetes via multiple mechanisms. JCI Insight. 3:e966002018.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu J, Chen D, Nie GD and Dai Z:
CD8(+)CD122(+) T-cells: A newly emerging regulator with central
memory cell phenotypes. Front Immunol. 6:4942015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mishra S, Srinivasan S, Ma C and Zhang N:
CD8+ regulatory T cell-a mystery to be revealed. Front Immunol.
12:7088742021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kim HJ, Wang X, Radfar S, Sproule TJ,
Roopenian DC and Cantor H: CD8+ T regulatory cells express the Ly49
Class I MHC receptor and are defective in autoimmune prone B6-Yaa
mice. Proc Natl Acad Sci USA. 108:2010–2015. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kim HJ, Verbinnen B, Tang X, Lu L and
Cantor H: Inhibition of follicular T-helper cells by CD8(+)
regulatory T cells is essential for self tolerance. Nature.
467:328–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Saitoh O, Abiru N, Nakahara M and Nagayama
Y: CD8+CD122+ T cells, a newly identified regulatory T subset,
negatively regulate Graves' hyperthyroidism in a murine model.
Endocrinology. 148:6040–6046. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
McLachlan SM, Nagayama Y, Pichurin PN,
Mizutori Y, Chen CR, Misharin A, Aliesky HA and Rapoport B: The
link between Graves' disease and Hashimoto's thyroiditis: A role
for regulatory T cells. Endocrinology. 148:5724–5733. 2007.
View Article : Google Scholar : PubMed/NCBI
|
